Procedural feasibility and clinical outcomes in propensity-matched patients treated with bioresorbable scaffolds vs new-generation drug-eluting stents.

@article{Sato2015ProceduralFA,
  title={Procedural feasibility and clinical outcomes in propensity-matched patients treated with bioresorbable scaffolds vs new-generation drug-eluting stents.},
  author={Katsumasa Sato and Azeem M Latib and Vasileios F. Panoulas and Hiroyoshi Kawamoto and Toru Naganuma and Tadashi Miyazaki and Antonio Colombo},
  journal={The Canadian journal of cardiology},
  year={2015},
  volume={31 3},
  pages={328-34}
}
BACKGROUND There is limited experience regarding the feasibility of the bioresorbable vascular scaffold (BVS) in "all-comer" populations. We evaluated the impact of BVS use on procedural factors and clinical outcomes compared with the new-generation drug-eluting stent (DES). METHODS We analyzed procedural feasibility and outcome data from 292 consecutive patients treated with either a new-generation DES or a BVS between May 2008 and May 2014 using propensity-score (PS) matching. RESULTS… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
10 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…